Research Article

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects

Figure 1

Plasma concentrations of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic obese and lean participants (obese: 6.58 [5–8.58] and control: 2.93 [1.8–5.23] ng/ml; ).